Sh3tc2-KO 基因敲除小鼠

1. Georgiou, Elena, Kagiava, Alexia, Sargiannidou, Irene, Christodoulou, Christina, Kleopa, Kleopas A. 2023. AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 3290-3307. doi:10.1016/j.ymthe.2023.08.020. https://pubmed.ncbi.nlm.nih.gov/37641403/

2. Yu, Pengfei, Lan, Haifeng, Song, Xianmin, Pan, Zengkai. 2020. High Expression of the SH3TC2-DT/SH3TC2 Gene Pair Associated With FLT3 Mutation and Poor Survival in Acute Myeloid Leukemia: An Integrated TCGA Analysis. In Frontiers in oncology, 10, 829. doi:10.3389/fonc.2020.00829. https://pubmed.ncbi.nlm.nih.gov/32637351/

3. Ozes, Burcak, Tong, Lingying, Moss, Kyle, Attia, Zayed, Sahenk, Zarife. 2024. AAV1.tMCK.NT-3 gene therapy improves phenotype in Sh3tc2-/- mouse model of Charcot-Marie-Tooth Type 4C. In Brain communications, 6, fcae394. doi:10.1093/braincomms/fcae394. https://pubmed.ncbi.nlm.nih.gov/39544702/

4. Selinger, Martin, Věchtová, Pavlína, Tykalová, Hana, Štěrba, Ján, Grubhoffer, Libor. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. In Computational and structural biotechnology journal, 20, 2759-2777. doi:10.1016/j.csbj.2022.05.052. https://pubmed.ncbi.nlm.nih.gov/35685361/